IBDEI2TF ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47269,1,3,0)
 ;;=3^Mixed Cellularity Classical Hodgkin Lymphoma,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,47269,1,4,0)
 ;;=4^C81.25
 ;;^UTILITY(U,$J,358.3,47269,2)
 ;;=^5001416
 ;;^UTILITY(U,$J,358.3,47270,0)
 ;;=C81.26^^209^2346^337
 ;;^UTILITY(U,$J,358.3,47270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47270,1,3,0)
 ;;=3^Mixed Cellularity Classical Hodgkin Lymphoma,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,47270,1,4,0)
 ;;=4^C81.26
 ;;^UTILITY(U,$J,358.3,47270,2)
 ;;=^5001417
 ;;^UTILITY(U,$J,358.3,47271,0)
 ;;=C81.27^^209^2346^338
 ;;^UTILITY(U,$J,358.3,47271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47271,1,3,0)
 ;;=3^Mixed Cellularity Classical Hodgkin Lymphoma,Spleen
 ;;^UTILITY(U,$J,358.3,47271,1,4,0)
 ;;=4^C81.27
 ;;^UTILITY(U,$J,358.3,47271,2)
 ;;=^5001418
 ;;^UTILITY(U,$J,358.3,47272,0)
 ;;=C81.28^^209^2346^339
 ;;^UTILITY(U,$J,358.3,47272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47272,1,3,0)
 ;;=3^Mixed Cellularity Classical Hodgkin Lymphoma,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,47272,1,4,0)
 ;;=4^C81.28
 ;;^UTILITY(U,$J,358.3,47272,2)
 ;;=^5001419
 ;;^UTILITY(U,$J,358.3,47273,0)
 ;;=C81.29^^209^2346^340
 ;;^UTILITY(U,$J,358.3,47273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47273,1,3,0)
 ;;=3^Mixed Cellularity Classical Hodgkin Lymphoma,Extranodal/Solid Organ Site
 ;;^UTILITY(U,$J,358.3,47273,1,4,0)
 ;;=4^C81.29
 ;;^UTILITY(U,$J,358.3,47273,2)
 ;;=^5001420
 ;;^UTILITY(U,$J,358.3,47274,0)
 ;;=C81.30^^209^2346^255
 ;;^UTILITY(U,$J,358.3,47274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47274,1,3,0)
 ;;=3^Lymphocyte Depleted Classical Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,47274,1,4,0)
 ;;=4^C81.30
 ;;^UTILITY(U,$J,358.3,47274,2)
 ;;=^5001421
 ;;^UTILITY(U,$J,358.3,47275,0)
 ;;=C81.31^^209^2346^256
 ;;^UTILITY(U,$J,358.3,47275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47275,1,3,0)
 ;;=3^Lymphocyte Depleted Classical Hodgkin Lymphoma,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,47275,1,4,0)
 ;;=4^C81.31
 ;;^UTILITY(U,$J,358.3,47275,2)
 ;;=^5001422
 ;;^UTILITY(U,$J,358.3,47276,0)
 ;;=C81.32^^209^2346^257
 ;;^UTILITY(U,$J,358.3,47276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47276,1,3,0)
 ;;=3^Lymphocyte Depleted Classical Hodgkin Lymphoma,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,47276,1,4,0)
 ;;=4^C81.32
 ;;^UTILITY(U,$J,358.3,47276,2)
 ;;=^5001423
 ;;^UTILITY(U,$J,358.3,47277,0)
 ;;=C81.33^^209^2346^258
 ;;^UTILITY(U,$J,358.3,47277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47277,1,3,0)
 ;;=3^Lymphocyte Depleted Classical Hodgkin Lymphoma,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,47277,1,4,0)
 ;;=4^C81.33
 ;;^UTILITY(U,$J,358.3,47277,2)
 ;;=^5001424
 ;;^UTILITY(U,$J,358.3,47278,0)
 ;;=C81.34^^209^2346^259
 ;;^UTILITY(U,$J,358.3,47278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47278,1,3,0)
 ;;=3^Lymphocyte Depleted Classical Hodgkin Lymphoma,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,47278,1,4,0)
 ;;=4^C81.34
 ;;^UTILITY(U,$J,358.3,47278,2)
 ;;=^5001425
 ;;^UTILITY(U,$J,358.3,47279,0)
 ;;=C81.35^^209^2346^260
 ;;^UTILITY(U,$J,358.3,47279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47279,1,3,0)
 ;;=3^Lymphocyte Depleted Classical Hodgkin Lymphoma,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,47279,1,4,0)
 ;;=4^C81.35
 ;;^UTILITY(U,$J,358.3,47279,2)
 ;;=^5001426
 ;;^UTILITY(U,$J,358.3,47280,0)
 ;;=C81.36^^209^2346^261
 ;;^UTILITY(U,$J,358.3,47280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47280,1,3,0)
 ;;=3^Lymphocyte Depleted Classical Hodgkin Lymphoma,Intrapelvic Nodes
